SEC Comment Letter 0000000000-24-005338 to AMGEN INC (AMGN) (CIK 0000318154) (AMGN)
AMGEN INC (AMGN) (CIK 0000318154)
Date: May 10, 2024 · CIK: 0000318154 · Accession: 0000000000-24-005338
AI Filing Summary & Sentiment
File numbers found in text: 001-37702
Letter
United States securities and exchange commission logo May 10, 2024 Peter Griffith Executive Vice President and Chief Financial Officer Amgen Inc. One Amgen Center Drive Thousand Oaks, CA 91320 Re:Amgen Inc. Form 10-K for Fiscal Year Ended December 31, 2023 File No. 001-37702 Dear Peter Griffith: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
United States securities and exchange commission logo
May 10, 2024
Peter Griffith
Executive Vice President and Chief Financial Officer
Amgen Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320
Re:Amgen Inc.
Form 10-K for Fiscal Year Ended December 31, 2023
File No. 001-37702
Dear Peter Griffith:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences